Dublin, May 22, 2023 (GLOBE NEWSWIRE) -- The "Global HLA Typing Market by Technology (PCR (SSO, SSP, Real Time), Sequencing (NGS, Sanger)), Product (Instrument, Reagent, Software), Application (Chimerism, Antibody Screening), End User (Hospital, Diagnolab, Academia) & Region - Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.
The HLA typing market is projected to reach USD 2.1 billion in 2028 from USD 1.4 billion in 2022 with a CAGR of 6.5% during the forecast period. The need and strong demand for clinical diagnostic procedures that can provide early diagnosis of infectious diseases, graft rejections, autoimmune diseases, and cancer have supported rising research activities. According to the Journal of Human Genetics (2015), research on the human leukocyte antigen (HLA) molecule (involved in immunity) has benefitted greatly from NGS technologies.
Thus, several high-throughput HLA-typing methods using NGS have been developed, as NGS technology enables complete HLA sequencing mechanisms, facilitating the understanding of HLA gene modulation, including transcription, regulation of gene expression, and epigenetics. Thus, government organizations and private players increasingly support research activities that target gene profiling and cross-matching in prospective subjects.
The molecular assay technologies segment to hold the largest share of the market in 2022
In 2022, the molecular assay technologies segment was projected to account for the highest share. The high market share of the segment is credited to the profits of molecular assay technologies like real-time sample analysis multi-sample study capabilities, high procedural efficacy, and low turnaround times.
The reagents & consumables is holding the largest share of the market in 2022
Based on product & service, The consumables & reagents segment reported for the highest share among all the three of the HLA typing market in 2022. The increasing use of reagents & consumables in HLA typing; the increasing acceptance of reagents & consumables in research studies; growing patient importance on early and effective treatment planning transplantation diagnosis over major geographies are predictable to determine market growth for this segment over the forecast period.
The HLA Typing market in North America region is projected to witness the highest growth over the forecast period.
North America reported the largest share of 45.0% of the HLA typing market in 2022. This highest share of North America is credited to the increased adoption of developed diagnostics tools, rising incidence and prevalence of chronic disorders in Canada and the US and growing technological developments.
While APAC is expected to witness significant growth in the coming years. The HLA typing market in the APAC region is expected to register a CAGR of 7.5% during the forecast period, primarily due to the growing number of hospitals in Asian countries and favorable government initiatives.
Market Dynamics
Drivers
- Rising Number of Organ Transplantation Procedures
- Rising Technological Advancements in Hla Typing
- Increasing Funding Investments for Research Activities
- Growing Prevalence of Infectious Diseases
Restraints
- High Cost of Hla Typing Products
- Limited Reimbursements for Target Procedures
Opportunities
- Rising Adoption of Cross-Matching and Chimerism Testing Procedures
- Growing Awareness of Organ Donations
Challenges
- Limited Number of Organ Donations and Long Waiting Lists for Transplantations
- Shortage of Skilled Professionals
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 217 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value (USD) in 2022 | $1.4 Billion |
| Forecasted Market Value (USD) by 2028 | $2.1 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Hla Typing Market, by Product & Service
6.1 Introduction
6.2 Reagents & Consumables
6.2.1 Wide Applications of Molecular Assay Techniques to Drive Market
6.3 Instruments
6.3.1 Growing Adoption of PCR and NGS Instruments Among CROs and Hospitals to Fuel Market
6.4 Software & Services
6.4.1 Rising Demand for Automation and Digitalization in Lab Procedures to Drive Market
7 Hla Typing Market, by Technology
7.1 Introduction
7.2 Molecular Assay Technologies
7.2.1 Pcr-based Molecular Assays
7.2.1.1 Sequence-Specific Primer-Pcr
7.2.1.1.1 Expanding Distribution Channels of Key Pcr Manufacturers to Support Market Growth
7.2.1.2 Sequence-Specific Oligonucleotide-Pcr
7.2.1.2.1 Rising Need for Sso-Pcr-based Molecular Assays in Disease Diagnosis to Drive Market
7.2.1.3 Real-Time Pcr
7.2.1.3.1 Increasing Preference for Genome-based Molecular Diagnostics to Support Market Growth
7.2.1.4 Other Pcr-based Molecular Assays
7.2.2 Sequencing-based Molecular Assays
7.2.2.1 Sanger Sequencing
7.2.2.1.1 Rising End-user Preference for Low-Cost and Efficient DNA Sequencing Technology to Drive Segment Growth
7.2.2.2 Next-Generation Sequencing
7.2.2.2.1 High Scalability, Low Turnaround Time, and High Throughput Capabilities to Drive Segment Growth
7.2.2.3 Other Sequencing-based Molecular Assays
7.3 Non-Molecular Assay Technologies
7.3.1 High Preference of Molecular-based Techniques to Restrain Market
8 Hla Typing Market, by Application
8.1 Introduction
8.2 Diagnostic Applications
8.2.1 Donor-Recipient Cross-Matching
8.2.1.1 Rising Need for Histocompatibility Cross-Matching in Organ Transplantation to Drive Market
8.2.2 Infectious Disease Testing
8.2.2.1 Rising Burden of Infectious Diseases to Drive Adoption of HLA Antigen Screening
8.2.3 Cancer Diagnosis & Prevention
8.2.3.1 Wide Availability of Advanced NGS Techniques to Drive Adoption of HLA Typing in Cancer Diagnostics
8.2.4 Transfusion Therapy
8.2.4.1 Minimal Risk of Fatal Disorders During Blood Transfusions to Drive Adoption of HLA Typing
8.2.5 Other Diagnostic Applications
8.3 Research Applications
8.3.1 Rising Funding for Research and Expanding Applications of HLA Typing to Drive Market
9 Hla Typing Market, by End-user
9.1 Introduction
9.2 Commercial Service Providers
9.2.1 Rising Establishment of Reference Laboratories in Emerging Economies to Drive Market
9.3 Hospitals and Transplant Centers
9.3.1 Increasing Demand for Advanced Equipment in Hospitals to Drive Market
9.4 Research Laboratories and Academic Institutes
9.4.1 Rising Government Support for Cancer Research to Boost Market Growth
10 Hla Typing Market, by Region
11 Competitive Landscape
12 Company Profiles
13 Appendix
Companies Mentioned
- Alpha Biotech Limited
- Bag Diagnostics GmbH
- BD
- Bio-Rad Laboratories, Inc.
- Biofortuna Limited
- Caredx, Inc.
- Creative Biolabs
- F. Hoffman-La Roche Ltd.
- Fujirebio
- Gendx
- Hansa Biopharma Ab
- Histogenetics LLC
- Hologic, Inc.
- Illumina, Inc.
- Immucor, Inc.
- Inno-Train Diagnostik GmbH
- Krishgen Biosystems
- Omixon Inc.
- Pacbio
- Qiagen N.V.
- Takara Bio Inc.
- Tbg Diagnostics Limited
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/r/om76l7
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
